Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.
Press releases published on June 5, 2025
ZenaTech Launches Drone as a Service (DaaS) for US Defense and Government Agencies with New Partnerships
GlobeNewswire
·
June 5, 2025
VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and …
Cocrystal Pharma’s Novel Norovirus Antiviral to be Presented at Department of Defense Medical Conference
GlobeNewswire
·
June 5, 2025
BOTHELL, Wash., June 05, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that its broad-spectrum protease inhibitor CDI-988 will be featured in an oral presentation at the 2025 Military Health System Research Symposium (MHSRS) …
NewAmsterdam Pharma to Host R&D Day on June 11, 2025
GlobeNewswire
·
June 5, 2025
NAARDEN, The Netherlands and MIAMI, June 05, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at …
IMUNON to Present at the Zacks SCR Life Sciences Virtual Investor Forum on June 12th
GlobeNewswire
·
June 5, 2025
LAWRENCEVILLE, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that Stacy Lindborg, Ph.D., President and Chief Executive Officer of …
Tempest Receives Orphan Drug Designation from the European Medicines Agency for Amezalpat for the Treatment of Patients with HCC
GlobeNewswire
·
June 5, 2025
EMA Orphan Drug Designation (ODD) builds on U.S. Food …
NANO Nuclear Energy Adds Intel Technologist and Former Department of Energy Deputy Chief Data Officer Seth Berl, Ph.D. to its Board of Directors
GlobeNewswire
·
June 5, 2025
New York, N.Y., June 05, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced that its …
ViGeneron Rebrands as VeonGen Therapeutics and Announces FDA Rare Pediatric Disease Designation and Clinical Progress for Lead Gene Therapy VG801 in Stargardt Disease
GlobeNewswire
·
June 5, 2025
VeonGen advances two proprietary, first-in-class gene therapies in the clinic, enabled by its novel vgRNA REVeRT and vgAAV technology platforms Lead program VG801 receives FDA Rare Pediatric Disease Designation and is progressing in a first-in-human Phase …
ZJK Industrial Co., Ltd. Ramps Up Production to Support Nvidia’s B40 Project, Expecting Significant YoY Revenue Growth
GlobeNewswire
·
June 5, 2025
Shenzhen, China, June 05, 2025 (GLOBE NEWSWIRE) -- ZJK Industrial Co., Ltd. (NASDAQ: ZJK) (“ZJK Industrial”, “ZJK” or the “Company”), a high-tech precision parts and hardware manufacturer for artificial intelligence (AI) infrastructure, consumer …
AgEagle Aerial Systems Provides Technology to Enhance European Security
GlobeNewswire
·
June 5, 2025
Government of Sweden orders eBee TAC Public Safety systems WICHITA, Kan., June 05, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS), a leading provider of advanced drone and aerial imaging solutions, is pleased to announce orders for …
Polpharma Group Supports Urgent EU Action to Safeguard Access to Medicines and Strengthen European Pharmaceutical Sovereignty
GlobeNewswire
·
June 5, 2025
AMSTERDAM, June 05, 2025 (GLOBE NEWSWIRE) -- Polpharma Group, a leading European pharmaceutical manufacturer, has joined fellow members of Medicines for Europe in signing an open letter addressed to the Prime Ministers and Ministers of Health of all 27 EU …
Clearmind Medicine Announces Enrollment of First Patient in Phase I/IIa Clinical Trial for Alcohol Use Disorder Treatment
GlobeNewswire
·
June 5, 2025
CMND-100 has the potential to provide an innovative and advanced treatment option for hundreds of millions of people around the world afflicted with Alcohol Use Disorder Vancouver, Canada, June 05, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: …
Kailera Therapeutics Appoints Adam Koppel and Christopher Hite to Board of Directors
GlobeNewswire
·
June 5, 2025
BOSTON and SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of obesity and related conditions, today …
Metsera to Present New Research Highlighting the Breadth and Momentum of its Next-Generation Obesity Portfolio at the 85th Scientific Sessions of the American Diabetes Association®
GlobeNewswire
·
June 5, 2025
Four presentations on MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, including two clinical data presentations Additional preclinical presentations on other differentiated portfolio assets, including MET-233i, a monthly, ultra …
Optiva Agentic AI BSS, Powered by Google's Gemini Models, Wins MVNOs World AI & Analytics Excellence Award
GlobeNewswire
·
June 5, 2025
TORONTO, June 05, 2025 (GLOBE NEWSWIRE) -- Optiva Inc. (TSX: OPT), a leader in powering the telecom industry with cloud-native billing, charging and revenue management software on private and public clouds, is honored to receive the MVNOs World award for …
NextGen Digital Expands Cloud AI Hosting & Digital Infrastructure Operations & Provides Corporate Update
GlobeNewswire
·
June 5, 2025
Fredericton, New Brunswick, June 05, 2025 (GLOBE NEWSWIRE) -- NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company”) is pleased to announce that it has expanded its fleet of computing workstations for its online …
Dyne Therapeutics to Present New Preclinical Data in Facioscapulohumeral Muscular Dystrophy at the FSHD Society International Research Congress
GlobeNewswire
·
June 5, 2025
- DYNE-302 Demonstrated Functional Improvement in an FSHD Preclinical Model - WALTHAM, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people …
Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025
GlobeNewswire
·
June 5, 2025
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to developing medicines for brain conditions with significant unmet need, will host an investor and media event on Thursday, June 12, …
Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia
GlobeNewswire
·
June 5, 2025
DUBLIN, June 05, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that LUMRYZTM has been granted Orphan Drug Designation (ODD) from the U.S …
Cellebrite to Acquire Corellium
GlobeNewswire
·
June 5, 2025
TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 05, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced its agreement to acquire Corellium, a …
THEIA Analytics Group Welcomes Stephen Baker as Strategic Growth Advisor
GlobeNewswire
·
June 5, 2025
WASHINGTON, June 05, 2025 (GLOBE NEWSWIRE) -- THEIA Analytics Group, Inc. (“THEIA” or the “Company”), a provider of quantitative risk insights, is pleased to announce that Stephen Baker has joined the THEIA team as a Strategic Advisor. A UK-based financial …